跳至主要内容
临床试验/JPRN-UMIN000013323
JPRN-UMIN000013323招募中未知

liver signal profiling and blood marker research for non-alcoholic fatty liver diseases - liver signal profiling and blood marker research for non-alcoholic fatty liver diseases

Saga Medical School Hiroshima University Yokohama City University Graduate School of Medicine Takeda Pharmaceutical Company0 个研究点目标入组 100 人开始时间: 2014年3月4日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Persons over 20g per day or 140g per week of alcohol intake 2) Patients who are suspicious of viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, sclerosing cholangitis, hemochromatosis, alpha1-antitrypsin deficiency, Wilson's disease, drug-induced hepatitis 3) Patients who showed clinical evidence of hepatic decompensation such as hepatic encephalopathy, ascites, variceal bleeding, or a serum bilirubin level greater than twofold the normal upper limit 4) Persons judged inappropriate for this study

研究者

发起方
Saga Medical School Hiroshima University Yokohama City University Graduate School of Medicine Takeda Pharmaceutical Company

相似试验